Wall Street Zen Adjusts Niagen Bioscience Rating: What Investors Need to Know
The investment landscape for Niagen Bioscience (NASDAQ:NAGE) has seen a recent adjustment, as analysts at Wall Street Zen revised their rating from a “strong-buy” to a “buy.”…